COIL — Coiled Therapeutics Share News
0.000.00%
RCS - Coiled Therapeutics - Participation in The Small Cap Showcase
Coiled Therapeutics - Director/PDMR Shareholding
Coiled Therapeutics - Interim Results to 30 June 2026
Coiled Therapeutics - Successful Enrolment Completed Across Two Cohorts
Brief: Coiled Therapeutics AO-252 In Phase I Clinical Development In U.S. For Advanced Solid Tumours
Coiled Therapeutics - First Patient Dosed with new Formulation of AO-252
RCS - Coiled Therapeutics - Company Presentation
Brief: Coiled Therapeutics Announces All AGM Resolutions Passed Except Resolution 5
Coiled Therapeutics - Appointment of Independent Non-Executive Director
RCS - Coiled Therapeutics - Life Sciences Investor Forum
RCS - Coiled Therapeutics - Proactive One2One Investor Forum
Brief: Coiled Therapeutics Grants 6.2 Million Share Options To Employees, Advisors, And PDMRs
Coiled Therapeutics - Grant of Share Options
Coiled Therapeutics - Issue of Equity
Coiled Therapeutics - Notice of Annual General Meeting
RCS - Coiled Therapeutics - Attendance at Endless Frontier Labs 2026
Coiled Therapeutics - Appointment of Non-Executive Director
Coiled Therapeutics - Annual Report & Financial Statements
RCS - Coiled Therapeutics - Presentation at 18th Annual World Cancer Congress